SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-16-005027
Filing Date
2016-04-29
Accepted
2016-04-29 14:40:45
Documents
9
Period of Report
2016-06-17
Effectiveness Date
2016-04-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A ttoo-20160617xdef14a.htm DEF 14A 1208888
2 GRAPHIC ttoo20160617xdef14a001.jpg GRAPHIC 4574
3 GRAPHIC ttoo20160617xdef14a002.jpg GRAPHIC 4910
4 GRAPHIC ttoo20160617xdef14a003.gif GRAPHIC 58758
5 GRAPHIC ttoo20160617xdef14a004.gif GRAPHIC 35841
6 GRAPHIC ttoo20160617xdef14a005.gif GRAPHIC 47847
7 GRAPHIC ttoo20160617xdef14a006.gif GRAPHIC 101217
8 GRAPHIC ttoo20160617xdef14a007.gif GRAPHIC 20722
9 GRAPHIC ttoo20160617xdef14a008.gif GRAPHIC 4324
  Complete submission text file 0001558370-16-005027.txt   1594071
Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Filer) CIK: 0001492674 (see all company filings)

IRS No.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36571 | Film No.: 161605545
SIC: 3841 Surgical & Medical Instruments & Apparatus